Journey Medical Corp (DERM)
3.76 -0.08 (-2.08%) 14:28 ET [NASDAQ]
3.76 x 700 3.78 x 2,800
Realtime by (Cboe BZX)
3.76 x 700 3.78 x 2,800
Realtime - - (-) -
for Thu, Jan 16th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Sales | 79,181 | 73,669 | 63,134 | 44,531 | 34,921 |
Cost of Goods | 26,660 | 30,775 | 32,084 | 14,594 | 10,532 |
Gross Profit | 52,521 | 42,894 | 31,050 | 29,937 | 24,389 |
Operating Expenses | 55,254 | 71,186 | 66,015 | 22,680 | 19,662 |
Operating Income | -2,073 | -27,517 | -34,881 | 7,851 | 5,259 |
Interest Expense | 1,698 | 2,019 | 7,034 | 698 | 255 |
Other Income | 139 | -29 | -445 | 0 | 0 |
Pre-tax Income | -3,632 | -29,565 | -42,360 | 7,153 | 5,004 |
Income Tax | 221 | 63 | 1,634 | 1,870 | 1,379 |
Net Income Continuous | -3,853 | -29,628 | -43,994 | 5,283 | 3,625 |
Net Income | $-3,853 | $-29,628 | $-43,994 | $5,283 | $3,625 |
EPS Basic Total Ops | -0.21 | -1.69 | -4.32 | 0.58 | 0.40 |
EPS Basic Continuous Ops | -0.21 | -1.69 | -4.32 | 0.58 | 0.40 |
EPS Diluted Total Ops | -0.21 | -1.69 | -4.32 | 0.49 | 0.36 |
EPS Diluted Continuous Ops | -0.21 | -1.69 | -4.32 | 0.49 | 0.36 |
EPS Diluted Before Non-Recurring Items | -0.21 | -1.69 | -4.32 | N/A | N/A |
EBITDA(a) | $5,281 | $-23,089 | $-29,749 | $9,367 | $6,523 |